Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosomal abnormalities in B-CLL.

D G Oscier1, M Fitchett, T J Hamblin

  • 1Royal Victoria Hospital, Bournemouth, UK.

Nouvelle Revue Francaise D'Hematologie
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Leukemia·2026
Same author

Problems of Anticoagulant Control-II, Which Test?

Bristol medico-chirurgical journal (1963)·2017
Same author

Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.

Leukemia·2016
Same author

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Leukemia & lymphoma·2016
Same author

CLL Trials in the United Kingdom the Medical Research Council CLL Trials 1, 2 and 3.

Leukemia & lymphoma·2016
Same author

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.

Leukemia·2016
Same journal

XIVth Congress of the French Society of Hematology. Paris, France, February 3-4, 1995. Abstracts.

Nouvelle revue francaise d'hematologie·1995
Same journal

Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.

Nouvelle revue francaise d'hematologie·1995
Same journal

Allogeneic transplantation of peripheral blood progenitor cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Selection and expansion of CD34+ cells.

Nouvelle revue francaise d'hematologie·1995
Same journal

Ex vivo hematopoietic cell expansion: a theoretical and technological challenge.

Nouvelle revue francaise d'hematologie·1995
See all related articles

Karyotypic abnormalities in B-cell chronic lymphocytic leukemia (B-CLL) patients are common and linked to shorter treatment-free survival and disease progression. However, trisomy 12 alone does not worsen prognosis compared to a normal karyotype.

Area of Science:

  • Hematology
  • Oncology
  • Cytogenetics

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous lymphoid malignancy.
  • Karyotypic abnormalities are frequently observed in B-CLL and are known prognostic factors.

Purpose of the Study:

  • To investigate the correlation between karyotypic abnormalities and clinical outcomes in B-CLL patients.
  • To assess the prognostic significance of specific chromosomal aberrations, including multiple abnormalities and trisomy 12.

Main Methods:

  • Karyotype analysis was performed on 141 patients diagnosed with B-CLL.
  • Treatment-free survival (TFS) and disease progression were analyzed in relation to cytogenetic findings.

Main Results:

Related Experiment Videos

  • 53% of B-CLL patients exhibited abnormal karyotypes.
  • Patients with karyotypic abnormalities had significantly shorter treatment-free survival, particularly those with multiple abnormalities.
  • Multiple abnormalities were associated with a higher tendency for disease progression.
  • Trisomy 12 as an isolated finding did not confer a worse prognosis compared to a normal karyotype.
  • Notably, 49% of patients in early-stage AO disease presented with abnormal karyotypes.

    • Conclusions:

    • Karyotypic abnormalities are prevalent in B-CLL and serve as critical indicators of prognosis.
    • The presence of multiple chromosomal aberrations is strongly linked to adverse outcomes, including shorter TFS and disease progression.
    • Specific cytogenetic findings, like isolated trisomy 12, require careful interpretation within the broader context of B-CLL staging and overall genomic landscape.